Audio Journal of Oncology“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
JOHN KASTELEIN, Academic Medical Center, Amsterdam REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans A drug which raises HDL and reduces circulating levels of LDL has nevertheless f
27/03/2007
Audio Journal of Oncology“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
JEAN-CLAUDE TARDIF, Montreal Heart Institute REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans Improvements in atheroma plaque have been achieved by infusing patients who have acut
27/03/2007
Audio Journal of OncologyCOURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
STEVEN NISSEN, Cleveland Clinic, OH REFERENCE: N Engl J Med 2007 356 Reporting from: American College of Cardiolgy New Orleans Two big studies published in the New England Journal of Medicine and pres
26/03/2007
Audio Journal of OncologyBioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results
Patrick Serruys Spencer King PATRICK SERRUYS, Erasmus University, Rotterdam COMMENT: SPENCER KING, Piedmont Hospital, Atlanta REFERENCE: Abstract 2402-3, American College of Cardiology New Orleans Six
26/03/2007
Audio Journal of OncologyIncreased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction
Soko Setoguchi Douglas Zipes SOKO SETOGUCHI, Brigham And Women’s Hospital, Boston COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis REFERENCE: Abstract 1018-148, American College of Ca
26/03/2007
Audio Journal of OncologyRapid Genotype Assay for Individualized Warfarin Dosing
Jeffrey Anderson Douglas Zipes JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis REFERENCE: Abstract 1020-89, American College of Cardiol
25/03/2007
Audio Journal of OncologyThrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
DAVID MOLITERNO, University of Kentucky, Lexington REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials An oral thrombin receptor antagonist, SCH 530348 has proved saf
25/03/2007
Audio Journal of OncologyWhen Good Cells Go Bad: The Stem Cell Origin of Cancers
DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling using the Wnt pathway may hold
16/03/2007
Audio Journal of Oncology6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates
HOOSEN COOVADIA, University of KwaZulu-Natal, Durban REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007 In the developing world brea
15/03/2007
Audio Journal of OncologyMaraviroc: New Antiretroviral Drug Shows Efficacy and Safety
HOWARD MAYER, Pfizer Global Research, New London CT MARK WAINBERG, McGill University, Montreal Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angele
13/03/2007
Audio Journal of OncologyIntegrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
ROY STEIGBIGEL, State University of New York at Stony Brook JOHN W. MELLORS, University of Pittsburgh REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections,
06/03/2007
Audio Journal of OncologyEntecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation
CHLOE THIO, Johns Hopkins University School of Medicine REFERENCE: Abstract: 136LB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007 Entecavir, used to tr
05/03/2007